# Nuvectis Pharma, Inc.: Form 8-K, filed May 5, 2026

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: 8-K
- Filed: 2026-05-05
- Accepted by EDGAR: May 5, 2026, 07:36 ET
- Period: 2026-05-05
- Accession: 0001104659-26-055264
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465926055264/tm2613389d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465926055264/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465926055264/tm2613389d1_8k.htm

Filed May 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-055264. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.
